Inactive Provider
This provider's NPI has been deactivated on 04/15/2026. The information on this page is historical and may no longer be current.
Total Payments
$6,167
2024 Payments
$371.77
Companies
22
Transactions
172
Medicare Patients
2,271
Medicare Billing
$237,950
Payment Breakdown by Category
Food & Beverage$6,152 (99.7%)
Education$15.55 (0.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,152 | 169 | 99.7% |
| Education | $15.55 | 3 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $1,036 | 11 | $0 (2021) |
| PFIZER INC. | $918.49 | 44 | $0 (2023) |
| GlaxoSmithKline, LLC. | $839.24 | 14 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $612.30 | 11 | $0 (2024) |
| ABBVIE INC. | $576.41 | 23 | $0 (2022) |
| Merck Sharp & Dohme LLC | $453.80 | 32 | $0 (2022) |
| Biohaven Pharmaceuticals, Inc. | $303.22 | 5 | $0 (2021) |
| Teva Pharmaceuticals USA, Inc. | $266.52 | 4 | $0 (2019) |
| Lilly USA, LLC | $255.15 | 6 | $0 (2020) |
| AngioDynamics, Inc. | $198.07 | 2 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $371.77 | 3 | GlaxoSmithKline, LLC. ($249.98) |
| 2023 | $456.65 | 6 | GlaxoSmithKline, LLC. ($236.85) |
| 2022 | $554.87 | 15 | Biohaven Pharmaceutical Holding Company Ltd. ($158.95) |
| 2021 | $1,272 | 43 | AbbVie Inc. ($472.12) |
| 2020 | $716.65 | 34 | Merck Sharp & Dohme Corporation ($244.86) |
| 2019 | $883.68 | 19 | Janssen Pharmaceuticals, Inc ($503.34) |
| 2018 | $765.35 | 24 | PFIZER INC. ($183.99) |
| 2017 | $1,147 | 28 | Janssen Pharmaceuticals, Inc ($405.35) |
All Payment Transactions
172 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/07/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: RESPIRATORY | ||||||
| 03/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $121.79 | General |
| Category: DIABETES | ||||||
| 03/20/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: RESPIRATORY | ||||||
| 12/07/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $94.74 | General |
| Category: DIABETES | ||||||
| 09/07/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $111.83 | General |
| Category: RESPIRATORY | ||||||
| 09/07/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: RESPIRATORY | ||||||
| 05/24/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $111.86 | General |
| 04/04/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $99.83 | General |
| Category: DIABETES | ||||||
| 03/13/2023 | PFIZER INC. | COMIRNATY (Biological), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $25.23 | General |
| Category: VACCINES | ||||||
| 12/19/2022 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $12.76 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/12/2022 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Seglentis | Food and Beverage | Cash or cash equivalent | $17.77 | General |
| Category: Cardiovascular | ||||||
| 12/07/2022 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: INSOMNIA | ||||||
| 12/06/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.80 | General |
| Category: NEUROSCIENCE | ||||||
| 09/22/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: DIABETES | ||||||
| 09/21/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $5.83 | General |
| Category: PRIMARY CARE | ||||||
| 09/01/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $8.95 | General |
| Category: PRIMARY CARE | ||||||
| 06/29/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: PRIMARY CARE | ||||||
| 06/07/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: RESPIRATORY | ||||||
| 03/17/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: PRIMARY CARE | ||||||
| 03/04/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $29.65 | General |
| Category: NEUROSCIENCE | ||||||
| 02/24/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $12.03 | General |
| Category: NEUROSCIENCE | ||||||
| 02/17/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $12.40 | General |
| Category: NEUROSCIENCE | ||||||
| 02/01/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: NEUROSCIENCE | ||||||
| 01/12/2022 | Merck Sharp & Dohme LLC | BELSOMRA (Drug), JANUVIA, JANUMET | Food and Beverage | In-kind items and services | $12.33 | General |
| Category: NEUROSCIENCE | ||||||
| 12/28/2021 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $11.90 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 490 | 911 | $123,178 | $54,701 |
| 2022 | 13 | 595 | 1,029 | $136,779 | $62,661 |
| 2021 | 12 | 614 | 1,151 | $141,209 | $72,998 |
| 2020 | 10 | 572 | 1,047 | $110,268 | $47,590 |
Total Patients
2,271
Total Services
4,138
Medicare Billing
$237,950
Procedure Codes
45
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 202 | 478 | $83,650 | $39,885 | 47.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 26 | 49 | $12,250 | $5,672 | 46.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 25 | 25 | $3,500 | $3,298 | 94.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 57 | 58 | $3,770 | $1,821 | 48.3% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2023 | 57 | 58 | $1,740 | $1,705 | 98.0% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 16 | 18 | $1,404 | $771.66 | 55.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 49 | 62 | $4,278 | $616.92 | 14.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 17 | 18 | $2,808 | $468.52 | 16.7% |
| J0694 | Injection, cefoxitin sodium, 1 gm | Office | 2023 | 30 | 128 | $9,472 | $444.93 | 4.7% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 11 | 17 | $306.00 | $17.77 | 5.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 215 | 483 | $84,525 | $41,886 | 49.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 85 | 121 | $18,876 | $7,662 | 40.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 32 | 36 | $8,575 | $4,490 | 52.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 25 | 25 | $3,500 | $3,384 | 96.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 49 | 50 | $3,250 | $1,537 | 47.3% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2022 | 49 | 50 | $1,500 | $1,469 | 97.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 43 | 65 | $4,485 | $695.05 | 15.5% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 15 | 17 | $1,224 | $579.72 | 47.4% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 26 | 29 | $2,638 | $527.95 | 20.0% |
| J0694 | Injection, cefoxitin sodium, 1 gm | Office | 2022 | 21 | 96 | $7,104 | $340.45 | 4.8% |
| 81002 | Urinalysis, manual test | Office | 2022 | 12 | 16 | $100.00 | $55.03 | 55.0% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2022 | 12 | 29 | $522.00 | $34.00 | 6.5% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 11 | 12 | $480.00 | $1.13 | 0.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 214 | 578 | $92,068 | $52,108 | 56.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 90 | 124 | $17,304 | $7,793 | 45.0% |
About Dr. Michael Gromis, MD
Dr. Michael Gromis, MD is a Specialist healthcare provider based in Fresno, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/21/2005. The National Provider Identifier (NPI) number assigned to this provider is 1528068442.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Gromis, MD has received a total of $6,167 in payments from pharmaceutical and medical device companies, with $371.77 received in 2024. These payments were reported across 172 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($6,152).
As a Medicare-enrolled provider, Gromis has provided services to 2,271 Medicare beneficiaries, totaling 4,138 services with total Medicare billing of $237,950. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Family Medicine
- Location Fresno, CA
- Active Since 07/21/2005
- Last Updated 04/04/2023
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1528068442
Products in Payments
- XARELTO (Drug) $608.72
- ELIQUIS (Drug) $523.27
- NURTEC ODT (Drug) $462.17
- JARDIANCE (Drug) $451.58
- INVOKANA (Drug) $426.90
- UBRELVY (Drug) $400.48
- AREXVY (Drug) $374.97
- BELSOMRA (Drug) $334.61
- TRELEGY ELLIPTA (Drug) $249.98
- TRULICITY (Drug) $245.30
- CHANTIX (Drug) $233.37
- Da Vinci Surgical System (Device) $191.18
- AJOVY (Drug) $127.41
- QVAR (Drug) $125.00
- EUCRISA (Drug) $124.97
- JANUVIA (Drug) $119.19
- QULIPTA (Drug) $98.03
- LINZESS (Drug) $77.90
- TOUJEO (Drug) $71.70
- ADVAIR (Drug) $56.08
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Fresno
Dr. Joseph Hawkins, M.d, M.D
Specialist — Payments: $717,878
Specialist $717,878
Dr. Bipin Joshi, Md, MD
Specialist — Payments: $82,184
Specialist $82,184
Dr. Daniel Swartz, Md, MD
Specialist — Payments: $73,941
Specialist $73,941
Lakhjit Sandhu, Md, MD
Specialist — Payments: $23,290
Specialist $23,290
Madhav Suri, M.d, M.D
Specialist — Payments: $16,778
Specialist $16,778
Anne Prentice, Md, MD
Specialist — Payments: $11,815
Specialist $11,815